首页> 美国卫生研究院文献>Neuro-Oncology >ET-47TRIFLOUROPROMAZINE AN APPROVED ANTIPSYCHOTIC DRUG ENHANCES TUMOR TREATING FIELDS TREATMENT EFFICACY IN VITRO
【2h】

ET-47TRIFLOUROPROMAZINE AN APPROVED ANTIPSYCHOTIC DRUG ENHANCES TUMOR TREATING FIELDS TREATMENT EFFICACY IN VITRO

机译:ET-47三氟吡嗪类药物一种批准的抗精神病药可增强肿瘤的治疗效果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor Treating Fields (TTFields) are low intensity, intermediate frequency alternating electric fields that disrupt proper spindle microtubules arrangement thus leading to mitotic arrest and subsequent cancer cell death. TTFields treated cells could escape cell death by exiting mitosis and entering interphase without chromosome segregation or cell division, a process also known as mitotic slippage. Triflouropromazine (TFP) is a clinically approved antipsychotic drug of the phenothiazine class that was recently reported to display anti slippage properties. The aim of this work is to determine whether TFP could increase TTFields efficacy based on its anti slippage properties. For this purpose, cell survival, volume and clonogenic potential of human glioblastoma (U87, U118) and breast adenocarcinoma (MCF-7, MDA-MB-231) cell lines were assessed following treatment with TTFields (3 V/cm) with cell line specific optimal frequency, with or without TFP. The percentage of cells that underwent mitotic slippage was determined using immunofluorescence imaging. TTFields as single application lead to a significant decrease in cell counts (26-44% reduction of control) and to cell volume increase (113-127% of control) in all cell lines. While TFP treatment as single agent had no effect on cell growth or cell volume, the combined treatment of TTFields and TFP resulted in an additional decrease in cell counts (31-58% reduction of control), further increase in cell volume (122-162% of control) and a reduced clonogenic potential. Immunofluorescence images of cells treated with TTFields demonstrated a significant increase in the number of cells that underwent slippage as compared to control cells or cells treated with TFP. Surprisingly, cells treated with TTFields and TFP demonstrated no decrease in the number of cells that underwent slippage. These results suggest that TFP enhances TTFields efficacy not by the inhibition of mitotic slippage. Further studies are underway in order to reveal the mechanism underlying the enhanced effect.
机译:肿瘤治疗场(TTFields)是低强度,中频交变电场,会破坏正常的纺锤体微管排列,从而导致有丝分裂阻滞和随后的癌细胞死亡。经TTFields处理的细胞可通过退出有丝分裂并进入相间而逃脱细胞死亡,而不会发生染色体分离或细胞分裂,这一过程也称为有丝分裂滑移。 Triflouropromazine(TFP)是吩噻嗪类的临床批准的抗精神病药物,最近有报道显示其具有防滑作用。这项工作的目的是确定TFP是否可以根据其防滑特性提高TTFields的功效。为此,在用TTFields(3 V / cm)细胞株处理后,评估了人胶质母细胞瘤(U87,U118)和乳腺腺癌(MCF-7,MDA-MB-231)细胞系的细胞存活率,体积和克隆形成潜力。有或没有TFP的特定最佳频率。使用免疫荧光成像确定经历有丝分裂滑移的细胞的百分比。 TTFields作为单一应用可导致所有细胞系中细胞计数显着减少(对照减少26-44%)和细胞体积增加(对照减少113-127%)。尽管TFP作为单一药物处理对细胞生长或细胞体积没有影响,但TTFields和TFP的联合处理导致细胞计数进一步减少(对照减少31-58%),细胞体积进一步增加(122-162) %的对照)和降低的克隆形成潜力。与对照细胞或经TFP处理的细胞相比,经TTFields处理的细胞的免疫荧光图像显示经历滑移的细胞数量显着增加。令人惊讶的是,用TTFields和TFP处理过的细胞没有显示出滑倒的细胞数量减少。这些结果表明,TFP不是通过抑制有丝分裂滑移来增强TTFields的功效。为了揭示增强作用的潜在机制,正在进行进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号